Is TG Therapeutics (NASDAQ:TGTX) Using Too Much Debt?

Simply Wall St18:56

TG Therapeutics to Participate in the Evercore HealthCONx Conference

GlobeNewswireNov 29 21:00

TG Therapeutics Is Maintained at Overweight by JP Morgan

Dow JonesNov 25 22:32 · Ratings

TG Therapeutics Analyst Ratings

BenzingaNov 25 22:22 · Ratings

J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $43

Futu NewsNov 25 20:39 · Ratings

A Closer Look at TG Therapeutics's Options Market Dynamics

BenzingaNov 22 01:18